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Received February 16, 2011; accepted April 22, 2011AbstractMassive premacular hemorrhage can cause sudden visual loss. We sought to evaluate the efficacy, safety and visual outcome of non-
vitrectomizing vitreous surgery with intravitreal tissue plasminogen activator (t-pa) for long-lasting thick premacular hemorrhage. This retro-
spective, interventional study examined three consecutive eyes of three patients who received nonvitrectomizing vitreous surgery with
intravitreal t-pa for the treatment of non-recent massive premacular hemorrhage. Detailed ophthalmoscopic examinations were performed pre-
and postoperatively to evaluate the visual outcome, the resolution of premacular hemorrhage and the changes in lenticular opacity.In all three
eyes, the premacular hemorrhage cleared after the procedure. Final best-corrected visual acuities improved from 6/30 to 6/10 in patient 1, 2/60 to
6/4 in patient 2, and 3/60 to 6/6 in patient 3. Operated and fellow eyes did not differ in terms of nuclear sclerosis. No complications from the
procedure were noted.In these selected cases, nonvitrectomizing vitreous surgery with intravitreal t-pa was an effective and safe alternative
treatment for non-recent massive premacular hemorrhage.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Premacular hemorrhage, or hemorrhage into the subhyaloid
or sub-internal limiting membrane (sub-ILM) space at the
macular area, can cause sudden visual loss. It results from
a variety of diseases, including diabetic retinopathy, retinal
arterial macroaneurysm, Valsalva maculopathy, hematologic
disorders, trauma and surgical complications.1,2 Patients with
premacular hemorrhage can be managed with observation,
while vitrectomy is also an option for nonclearing hemor-
rhage. However, the hemorrhage may take a long time to clear
spontaneously, and it may result in late macular traction and
permanent macular damage.1 Vitrectomy may result in post-
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doi:10.1016/j.jcma.2011.08.007In recent years, several alternative treatments have been
proposed to accelerate blood clearance, such as mem-
branotomy with different laser modalities, intravitreal injec-
tion of tissue plasminogen activator (t-pa) and pneumatic
displacement.2,4e6 Outcomes vary by approach. Laser mem-
branotomy, which creates an opening to drain the hemorrhage,
is reported effective in patients with premacular hemorrhage
of no longer than 21 days’ duration; however, it may have
limited effects and take longer to drain in patients with
hemorrhages of more than two weeks’ duration.7
In 1999, Saito et al.8 advocated nonvitrectomizing vitreous
surgery for macular pucker to prevent postoperative nuclear
sclerosis; the procedure consisted of epi-retinal membrane
peeling without cutting or removing the vitreous. We applied
this concept to manage premacular hemorrhage, and a bent
needle was used to create a membranotomy to immediately
drain the blood into the vitreous cavity. The results were
favorable in patients with recent premacular hemorrhage;9
however, we observed slow or no drainage through thehinese Medical Association. All rights reserved.
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2 weeks. Consequently, we added adjuvant intravitreal t-pa to
promote blood drainage in sustained hemorrhage lasting
longer than two weeks. In this retrospective series, we evalu-
ated the resolution of hemorrhage, visual outcome and
changes in lenticular opacity after surgery.
2. Case report
The study was approved by the hospital institutional review
board (IRB) committee. Three eyes of three consecutive
patients with thick premacular hemorrhage secondary to
different causes were enrolled in this study between November
2007 and August 2008 (Table 1). Only massive, subhyaloid or
subinternal limiting membrane (sub-ILM) hemorrhage block-
ing the view of the fovea was considered for treatment. Pre-
macular hemorrhages along with other complicated situations
were all excluded, including retinal detachment, vitreous
hemorrhage, proliferative vitreoretinopathy, proliferative dia-
betic retinopathy and significant cataracts that interfered with
intraoperative visibility.
Details from preoperative ophthalmological examinations
were recorded, including visual acuity, intraocular pressure, slit
lamp biomicroscopy, indirect ophthalmoscopy and fundus
photographs after dilation of the pupils with 10% phenylephrine
and 1% tropicamide. After the procedure was explained,
informed consent was obtained from all patients, and all surgical
procedures were performed by the same surgeon (TT Wu).
We performed the procedure with the patient in the supine
position under local anesthesia. After prepping the eye with
5% betadine, nonvitrectomizing vitreous surgery was done
using transconjunctival sutureless 25-gauge vitrectomy tech-
nique without creating an infusion port. The trocar puncture
and cannula insertion were made at the pars plana, only in the
superotemporal and superonasal quadrants. Through the
cannula, a fiberoptic light source and a bent 25-gauge needle
filled with 50 mg/0.1 ml t-pa were introduced while using
a hand-held vitrectomy lens. Without cutting the vitreous or
performing any other intraocular maneuver, we used the bent
needle to perform the membranotomy directly. The created
opening on the anterior surface of the membrane provided an
access for subhyaloid or sub-ILM hemorrhage to enter the
vitreous cavity. At the conclusion of the procedure, we
injected 50 mg/0.1 ml t-pa through the needle. After theTable 1
Clinical characteristics of patients with non-recent premacular hemorrhage before
Patient Sex/Age
(years)
Eye Cause Duration of symptoms
(days)
Si
(D
1 M/52 L RAM 35 11
2 F/27 R Terson syndrome 30 10
3 M/52 L Ocular injury 15 9
F, female; M, male; R, right eye; L, left eye; RAM, retinal arterial macroaneurysm
* Degree of nuclear sclerosis was graded according to the scale reported by Thom
0.75, minimal cataract.cannulas and their plugs were withdrawn one after the other,
the scleral wounds sealed without wound leaks. All patients
were examined at 1 day, 1 week, 3 weeks, 5 weeks, and
3 months postoperatively, and then every 3 months thereafter.
Slit lamp examination and indirect ophthalmoscopy were
performed at every visit. The efficacy and outcome of the
procedure were assessed by the drainage and clearing of the
premacular hemorrhage, visual improvement and changes in
lenticular opacity.
The recorded data for all patients included the following:
gender, age, lens status, cause and duration of hemorrhage,
fundus photographs, preoperative best-corrected visual acuity
and postoperative best-corrected visual acuity at each follow-
up time point. We graded lens opacity using the scale reported
previously by Thompson et al.3 : 0, clear lens; 0.50, trace
cataract; 0.75, minimal cataract; 1.00, mild (judged to have no
effect on visual acuity); 2.00, moderate (decreasing visual
acuity, but good view of retina by contact lens bio-
microscopy); 3.00, moderately severe (impaired visual acuity
and some distortion or impaired view of retina); and 4.00,
severe (very poor view of retina).
Table 1 provides a summary of the collected data. Of
the three patients, one was a 27-year-old female and two
were 52-year-old males. All three eyes were phakic. Causes
of premacular hemorrhage were retinal arterial macro-
aneurysm, head injury and ocular trauma. The time to
surgery ranged from 15 to 35 days. Preoperative visual
acuities ranged from 2/60 to 6/30. After nonvitrectomizing
vitreous surgery with intravitreal t-pa, final vision improved
to 6/10, 6/4, and 6/6.
Patient 1 was a 52-year-old male with a history of poorly
controlled hypertension who was evaluated because of blurred
vision in his left eye for more than one month. His best-
corrected visual acuity was 6/6 in the right eye and 6/30 in
the left eye, and grade of nuclear sclerosis was 0.5 in both
eyes. Dilated fundus examination revealed retinal arterial
macroaneurysm with premacular hemorrhage of 11 disc areas
in the left eye (Fig. 1A). Faint vitreous hemorrhage was
noticed soon after the operation (Fig. 1B), and the sclerotomy
wound sealed well without signs of hypotony or endoph-
thalmitis. Vision recovered to 6/10 in the left eye, and the
residual vitreous hemorrhage disappeared completely in two
months (Fig. 1C). Both vision and lens status remained stable
during three years of follow-up.and after non-vitrectomizing vitreous surgery and intravitreal t-pa.
ze
D)
BCVA Grade of
nuclear
sclerosis*
Vitreous clear-up
time (months)
Follow-up
(months)
Initial Final Initial Final
6/30 6/10 0.5 0.5 2 36
2/60 6/4 0 0 2 24
3/60 6/6 0.75 0.75 2 30
; DD, disc diameter; BCVA, best-corrected visual acuity.
pson et al.3 at initial and final examinations: 0, clear lens; 0.50, trace cataract;
Fig. 1. Patient 1. A. Retinal arterial macroaneurysm (arrow) with premacular hemorrhage of 11 disc areas in size in the left eye. There were two levels of blood
accumulation: subhyaloid (delineated by arrowheads) and subinternal limiting membrane (asterisk) hemorrhage (visual acuity¼ 6/30). B. On the day after 25-
gauge nonvitrectomizing vitreous surgery and intravitreal injection of t-pa, the premacular hemorrhage was drained, with faint vitreous hemorrhage and
residual subinternal limiting membrane hemorrhage superior to the optic disc. C. The residual blood cleared gradually within two months (visual acuity¼ 6/10).
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accident with the sequelae of subdural and epidural hematoma.
This patient was referred due to blurred vision in the right eye
for more than one month. She had clear lens in both eyes, and
best-corrected vision was 2/60 in the right eye and 6/5 in the
left eye. Fundus examination revealed premacular hemorrhage
of 10 disc areas in the right eye and papilloedema in both eyes
(Fig. 2A). Nonvitrectomizing vitreous surgery with 25-gauge
sutureless equipment was carried out with posterior hyaloid
membrane peeling and intravitreal injection of t-pa. Faint
vitreous hemorrhage was noted after the operation (Fig. 2B).
Six weeks later, the vision returned to 6/4 in the right eye with
residual vitreous opacity inferiorly (Fig. 2C). Vision was
stable, and the lens remained crystal clear two years after the
operation.
Patient 3 was a 52-year-old male with blurred vision in the
left eye for 15 days due to trauma. Best-corrected vision was
6/6 in the right eye and 3/60 in the left eye, and degree of
nuclear sclerosis was 0.75 in both eyes. Intraocular pressure
and anterior segment were normal. Indirect ophthalmoscopy
revealed premacular hemorrhage of 9 disc areas in the left eye
(Fig. 3A). After this procedure, faint vitreous hemorrhage was
noted, but it was absorbed completely within two months, with
visual recovery to 6/6 in the left eye (Fig. 3B). Lens status and
vision remained stable after 30 months.
The surgery was accomplished without complications in all
three eyes. In all cases, most of the premacular hemorrhage
drained into the vitreous cavity on the first postoperative day.
The vitreous hemorrhage would gravitate to the lower part ofFig. 2. Patient 2. A. Premacular hemorrhage (delineated by arrowheads) of 10 disc a
On the day after the operation, faint vitreous hemorrhage was noted. C. Six weeks
acuity¼ 6/4).the vitreous cavity; as a result, all patients experienced visual
improvement on the day after surgery. Neither postoperative
hypotony nor infection was noticed during follow-up. For all,
vitreous hemorrhage cleared completely within two months.
All patients were followed up for at least 2 years (range,
24-36 months), and all three eyes had at least 4 lines of
Snellen visual acuity improvement at final follow-up. There
were no late complications, including retinal tear, retinal
detachment or endophthalmitis, during follow-up. All three
patients had equal degree of nuclear sclerosis in both eyes
before the operation, and they remained unchanged after the
operation. At final examination, all three phakic eyes and the
fellow eyes were no different in terms of degree and
progression of nuclear sclerosis (Table 1).
3. Discussion
Premacular hemorrhage can cause sudden visual loss. The
hemorrhagemay occur in a space created by a posterior vitreous
detachment (subhyaloid or retrohyaloid hemorrhage) or
between the internal limiting membrane and the retinal nerve
fiber layer (sub-ILM hemorrhage), but the definite location of
the premacular hemorrhage may be difficult to distinguish
clinically. Reported causes of premacular hemorrhage have
included ocular injury, Terson syndrome, shaken baby
syndrome, retinal arterial macroaneurysm, valsava maculop-
athy, diabetic retinopathy, branch retinal vein occlusion,
surgical complications, anemia and various hematological
disorders.1,2 Several options are feasible to manage thisreas in size and papilloedema (arrow) in the right eye (visual acuity¼ 2/60). B.
later, residual vitreous opacity had gravitated inferiorly in the right eye (visual
Fig. 3. Patient 3. A. Fundus revealed premacular hemorrhage (delineated by arrowheads) of 9 disc areas in the left eye. B. After non-vitrectomizing vitreous
surgery, the residual hemorrhage was resorbed gradually.
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ously, but this process can take several months. The toxic
effects of iron released from the hemoglobin may cause irre-
versible damage to the retina and many intraocular structures;
in addition, formation of an epiretinal membrane with late
macular traction in some cases may result in poor visual
prognosis.1 Vitrectomy is a well established method for
managing nonclearing premacular hemorrhage, and it can
remove the hemorrhage immediately to restore vision while
allowing anatomical definition of the exact location of the
hemorrhage and histological analysis of the removed anterior
wall of the hemorrhage. However, complications include
bleeding, retinal breaks, retinal detachment, macular injury,
proliferative vitreoretinopathy, accidental lens damage and
nuclear sclerosis.3,10 Although the incidence of post-vitrectomy
nuclear sclerotic cataract is relatively low in patients younger
than 50 years old, it increases over time, as observed during
long-term follow-up.10 Subsequently, a second surgery is
usually required for cataract extraction.
Laser photodisruption of the surface membrane entrapping
the hemorrhage has been reported using several different types
of lasers: pulsed Q-switching Nd:YAG, frequency-doubled
Nd:YAG, argon and krypton laser.2,4,5,11 Laser mem-
branotomy creates an exit for the blood into the vitreous cavity,
leading to prompt visual improvement and facilitating blood
resorption. However, accidental retinal injury by laser may
occur,12 caused by direct or reflected beams of the laser.
Complications of the laser modality are subretinal, retinal,
choroidal and vitreous hemorrhage; retinal hole; and subsequent
macular pucker and macular hole formation.12 The probability
of retinal and choroidal injury is increased when the funda-
mental mode beam is focused less than 4 mm from the retinal
surface.12 Furthermore, several pulses are usually attempted
before creating a patent membranotomy, and the built-up laser
energy might somehow injure the intraocular tissues.
Saito et al. reported using nonvitrectomizing vitreous
surgery for macular pucker to prevent postoperative nuclear
sclerotic cataracts.8 We applied this technique to treat pre-
macular hemorrhage.9 As in laser membranotomy, the opening
created at the most dependent part of the anterior surface of
the hemorrhage allows the blood to enter the vitreous cavity,permitting immediate drainage. The opening can be easily
sized to optimize drainage, releasing the trapped blood from
the subhyaloid or sub-ILM area. The hemorrhage obstructing
the macular area sinks to the lower part of the vitreous, leading
to prompt improvement in visual function with resolution of
the hemorrhage.
Consequently, nonvitrectomizing vitreous surgery may save
time, compared with standard vitrectomy.9 Use of 25-gauge
sutureless equipment may make the procedure much easier
and faster, and speed wound healing, as in our patients.
It has been noted that Nd:YAG laser membranotomy was
effective in cases of premacular hemorrhages of less than three
weeks’ duration; however, in cases with more than two weeks’
duration, drainage of the hemorrhage was slower, with little
change immediately after the treatment.7 In our patients with
relatively longer duration of premacular hemorrhage, we
observed slow or no drainage after creating a membranotomy.
Subsequently, we injected t-pa intravitreally to accelerate lysis
of blood clots, improve the rate of clearance, and promote
a good surgical outcome.
Intraocular injection of t-pa has been administered as an
adjuvant therapy for eye diseases for many years. T-pa is
a fibrinolytic agent which can dissolve fibrin clots rapidly and
is widely used for lysis of intraocular fibrin, hyphema, sub-
macular hemorrhage, premacular hemorrhage, postvitrectomy
fibrin formation and occluded peripheral iridectomy.6,13
Besides inducing clot liquefaction, t-pa may also enhance
separation of the vitreous, loosening the vitreoretinal adher-
ence that confines the premacular hemorrhage;6 therefore, the
resultant mobile blood may be drained more easily.
The dosage at which t-pa causes retinal toxicity is not clear,
but some studies found no toxic reactions after intraocular
injection of up to 50 mg.14,15 T-pa may raise the risk of
rebleeding, hyphema and vitreous hemorrhage. In our cases, it
did not produce serious adverse effects. As in patients without
t-pa in a previous report,9 the resulting vitreous hemorrhage
was so mild that it did not obscure or impede the visual axis
significantly. Vision improved soon after drainage of dense
hemorrhage from the premacular area.
In all three patients, the resorption of residual vitreous
hemorrhage took about 2 months. No complications, including
578 T.-T. Wu et al. / Journal of the Chinese Medical Association 74 (2011) 574e578hypotony, retinal detachment or endophthalmitis, was noted,
and the lens status remained stable and comparable to the
fellow eye at last follow-up visit (range, 24-36 months).
The extent of visual improvement and prognosis accorded
with the underlying causes and preexisting macular diseases.
In our study, final vision recovered to a level above or equal to
6/6 in patients without significant macular pathology (patients
2 and 3), while the final vision of patient 1 was less desirable.
This result was probably due to some underlying macular
pathology and concurrent subretinal hemorrhage from retinal
arterial macroaneurysm in the patient. Raymond4 also found
poor visual outcome after Nd:YAG laser treatment in one case
because of persistent, pre-existing subretinal hemorrhage from
a macroaneurysm. Moreover, eyes with premacular hemor-
rhage secondary to macroaneurysm or diabetic retinopathy
may need longer to recover.5
In this study, we achieved good outcomes of non-
vitrectomizing vitreous surgery and intravitreal t-pa injection in
three patients with non-recent premacular hemorrhage. An
injection of intravitreal t-pa may help manage longstanding
premacular hemorrhage. There was neither complication nor
detectable progression of nuclear sclerosis during follow-up.We
conclude this procedure may be a safe and effective alternative
treatment for selected patients with non-recent premacular
hemorrhage. It shows promise in eliminating the need for stan-
dard vitrectomy and preventing postoperative nuclear sclerosis.
However, due to strict candidate selection, we had limited case
number and lacked a control group. Further large-scale and
long-term studies, preferably in a prospective, randomized
design of all available treatment modalities, are necessary to
define the benefits and disadvantages of this procedure.
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